 (1) the term 'manufacture, preparation, propagation, compounding, or processing' shall include repackaging or otherwise changing the container, wrapper, or labeling of any drug package in furtherance of the distribution of the drug from the original place...  Code of Federal Regulations 21 Parts 800 to 1299 Food and Drugs: Revised as ...autors: Office of the Federal Register, Office of the Federal Register (U.S.) Staff - 2006 - 796 lapasFragmentu skats - Par šo grāmatu
 | United States, United States. Congress. House. Committee on Energy and Commerce - 1993 - 476 lapas
...or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the...makes final delivery or sale to the ultimate consumer or user; and (b) On or before December 31 of each year every person who owns or operates any establishment... | |
 | DIANE Publishing Company - 1994 - 226 lapas
...or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the...makes final delivery or sale to the ultimate consumer or user; and (b) On or before December 31 of each year every person who owns or operates any establishment... | |
 | International Validation Forum - 1996 - 860 lapas
...or labeling of any drug package or device package in furtherance of the distribution of the drug or device from the original place of manufacture to the...makes final delivery or sale to the ultimate consumer or user; and (2) the term "name" shall include in the case of a partnership the name of each partner... | |
 | 1998 - 200 lapas
...wrapper, or labeling of any blood product package in furtherance of the distribution of the blood product from the original place of manufacture to the person...makes final delivery or sale to the ultimate consumer. (e) Commercial distribution means any distribution of a blood product except pursuant to the investigational... | |
 | Steven Strauss - 2000 - 454 lapas
...changing the container, wrapper, or labeling of any drug package to further the distribution of the drug from the original place of manufacture to the person...makes final delivery or sale to the ultimate consumer. 21 CFH 207.3(aH8) Marketing Application an application for a new drug submitted under section 505(b)... | |
 | Karen M. Becker, John J. Whyte - 2007 - 360 lapas
...importer as "any person who imports a device into the United States and who furthers the marketing of a device from the original place of manufacture to the...person who makes final delivery or sale to the ultimate user, but who does not repackage or otherwise change the container, wrapper, or labeling of the device... | |
 | 1979 - 760 lapas
...container, wrapper, or labeling of any drug package in furtherance of the distribution of the drug from the original place of manufacture to the person...final delivery or sale to the ultimate" consumer; "(2) the term 'name' shall include in the case of a partnership the name of each partner and, in the case... | |
 | 1968 - 636 lapas
...container, wrapper, or labeling of any drug package in furtherance of the distribution of the drug from the original place of manufacture to the person...makes final delivery or sale to the ultimate consumer. (d) The term "wholesaling, jobbing, or distributing of depressant, stimulant, or hallucinogenic drugs"... | |
 | 1969 - 404 lapas
...the container, wrapper, or labeling of such drugs in furtherance of the distribution of such drugs from the original place of manufacture to the person...makes final delivery or sale to the ultimate consumer. (d) Pharmacies, hospitals, clinics, and public health agencies who have on hand or maintain a stock... | |
| |
